FDA approves pediatric treatment for Chagas disease
(HealthDay)—Benznidazole has been approved by the U.S. Food and Drug Administration to treat the tropical parasitic infection Chagas disease, in children aged 2 to 12.
Aug 31, 2017
0
0
(HealthDay)—Benznidazole has been approved by the U.S. Food and Drug Administration to treat the tropical parasitic infection Chagas disease, in children aged 2 to 12.
Aug 31, 2017
0
0
The World Health Organisation (WHO) has estimated that 700,000 people around the world die annually from drug resistant infections. It also listed drug resistant gonorrhoea, a sexually transmitted disease caused by the Neisseria ...
Aug 7, 2017
0
0
New drugs are urgently needed to treat gonorrhoea, a sexually-transmitted disease threatening to veer out of control as it develops resistance to existing antibiotics, the UN's health agency said Friday.
Jul 7, 2017
0
4
Patients with bloodstream infections could avoid treatment with a combination of antimicrobial therapies if they are given the right drug as early as possible and if they are classified as at low risk of death. This would ...
Apr 23, 2017
0
85
The death last year of a woman in Reno, Nev., from an infection resistant to every type of antibiotic available in the U.S. highlights how serious the threat of antimicrobial resistance has become.
Feb 28, 2017
0
0
Ten million people could die by 2050 unless sweeping global changes are agreed to tackle increasing resistance to antibiotics, which can turn common ailments into killers, a report warned Thursday.
May 19, 2016
0
4
A Purdue University researcher has developed a novel strategy on identifying antimicrobial drugs to better treat bacterial and fungal infections, which could produce significant impacts that leapfrog the drug development ...
Mar 10, 2016
0
5
Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs"—infections that increasingly don't respond to drugs and threaten millions of people in countries rich ...
Jan 21, 2016
0
56
Results from the first phase 3 HIV study to enroll only women show improved safety and efficacy of the drug Stribild over multi-pill antiretroviral drug regimens. The research was presented at ASM's 55th Interscience Conference ...
Sep 21, 2015
0
3
The global pharmaceutical industry should set up a $2.0 billion (1.8-billion euro) global innovation fund to help kickstart research into developing more resistant antibiotics, experts said on Thursday.
May 14, 2015
0
7